Since organic chemistry deals directly with the nature and structure of medications, as well as the nature and structure of our bodies, it is one of the major sciences in general chemistry studies and one of the most significant chemical sciences in pharmaceutical and medical studies. Organic chemistry is simply defined as the study of any compound that contains a carbon atom inside of it. There are approximately 5 million compounds in nature, of which 4.5 million are organic. In addition, a large number of other carbon-containing compounds can now be produced artificially in laboratories. It is important to note that we can also produce organic compounds (containing carbon) from inorganic compounds, as in the synthesis of organic compounds. In the synthesis of urea, as shown in the image below, urea is generated from ammonium cyanate (inorganic) by the application of heat. This illustrates how we may produce organic molecules (containing carbon) from inorganic compounds as well. Pharmaceutical organic chemistry includes analytical methods, pharmacology, metabolism, quality control, and drug chemistry in addition to illness treatments and cures. Many students studying pharmaceutical chemistry will eventually work in a lab. Pharmaceutical chemistry prepares students for professions in biotechnology, pharmaceutical firms, research institutions, and other fields.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia